Favorable Outcome of COVID-19 Pneumonia in a Kidney Transplant Recipient Treated with Tocilizumab

Abstract EN

The presentation of COVID-19 pneumonia in kidney transplant recipients is similar to that of the general population.

However, in the former, it may have a worse clinical course.

We report a kidney transplant patient affected by COVID-19 pneumonia whose condition worsened 9 days after the initial presentation.

As no therapeutic guidelines on the subject are currently available, here we share our approach in the management of the immunosuppressive medications and the antiviral therapy and compare them to the scarce available data.

We also expose the use of tocilizumab in our patient with excellent results.